Brain Metastases in EGFR-mutant NSCLC: Outcome of Osimertinib plus /- Radiation Therapy in a Real-World Canadian Cohort

被引：0
|
作者：
Litt, I. [1 ]
Gibson, A. [2 ]
Dean, M. [2 ]
Elegbede, A. [2 ]
Bebb, G. [2 ]
Cheung, W. [1 ]
Pabani, A. [1 ]
机构：
[1] Alberta Hlth Serv, Calgary, AB, Canada
[2] Univ Calgary, Calgary, AB, Canada
来源：
JOURNAL OF THORACIC ONCOLOGY | 2022年 / 17卷 / 09期
关键词：
Non-small cell lung cancer; Targeted Therapies; Brain Metastases;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP08.02-07
引用
收藏
页码：S434 / S434
页数：1
相关论文
共 50 条
  • [41] Tepotinib plus Osimertinib in EGFR-mutant NSCLC with MET Amplification Following 1L Osimertinib: INSIGHT 2 Primary Analysis
    Kim, T. M.
    Guarneri, V.
    Jye, V. P.
    Khaw, L. B.
    Yang, J. -J.
    Wislez, M.
    Huang, C.
    Kin, L. Chong
    Mazieres, J.
    Tho, L. M.
    Hayashi, H.
    Nhung, N.
    Chia, P. L.
    De Marinis, F.
    Raskin, J.
    Zhou, Q.
    Finochhiaro, G.
    Le, X.
    Tan, D.
    Brutlach, S.
    O'Brate, A.
    Adrian, S.
    Berghoff, K.
    Ellers-Lenz, B.
    Karachaliou, N.
    Wu, Y. -L.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S94 - S94
  • [42] Tepotinib plus osimertinib in EGFR-mutant NSCLC with MET amplification following first-line osimertinib: INSIGHT 2 primary analysis
    Le, Xiuning
    Kim, Tae Min
    Guarneri, Valentina
    Voon, Pei Jye
    Lim, Boon Khaw
    Yang, Jinji
    Wislez, Marie
    Huang, Cheng
    Liam, Chong Kim
    Mazieres, Julien
    Lye Mun Tho
    Hayashi, Hidetoshi
    Nguyen Nhung
    Chia, Puey Ling
    De Marinis, Fillippo
    Raskin, Jo
    Zhou, Qinghua
    Finochhiaro, Giovanna
    Tan, Daniel
    Brutlach, Sabine
    O'Brate, Aurora
    Adrian, Svenja
    Berghoff, Karin
    Ellers-Lenz, Barbara
    Karachaliou, Niki
    Wu, Yi-Long
    MOLECULAR CANCER THERAPEUTICS, 2023, 22 (12)
  • [43] TYROSINE KINASE INHIBITORS WITHOUT RADIATION THERAPY FOR BRAIN METASTASES FROM EGFR-MUTANT ADENOCARCINOMA OF LUNG
    Iuchi, T.
    Shingyoji, M.
    Sakaida, T.
    Yokoi, S.
    Itakura, M.
    Kawasaki, K.
    Hasegawa, Y.
    Kageyama, H.
    Iizasa, T.
    ANNALS OF ONCOLOGY, 2012, 23 : 144 - 145
  • [44] Tepotinib plus Osimertinib in EGFR-mutant NSCLC with MET Amplification Following 1L Osimertinib: INSIGHT 2 Primary Analysis
    Kim, Tae Min
    Guarneri, Valentina
    Voon, Pei Jye
    Lim, Boon Khaw
    Yang, Jin-ji
    Wislez, Marie
    Huang, Cheng
    Liam, Chong Kin
    Mazieres, Julien
    Tho, Ye Mun
    Hayashi, Hidetoshi
    Nhung Nguyen
    Chia, Puey Ling
    de Marinis, Filippo
    Raskin, Jo
    Zhou, Qinghua
    Finocchiaro, Giovanna
    Le, Xiuning
    Tan, Daniel
    O'Hara, Richard M., Jr.
    Brutlach, Sabine
    O'Brate, Aurora
    Adrian, Svenja
    Berghoff, Karin
    Ellers-Lenz, Barbara
    Karachaliou, Niki
    Wu, Yi-Long
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (07) : E38 - E38
  • [45] Chemotherapy Plus Immunotherapy Versus Chemotherapy Plus Bevacizumab Versus Chemotherapy Alone in EGFR-Mutant NSCLC After Progression on Osimertinib
    White, Maya N.
    Piper-Vallillo, Andrew J.
    Gardner, Rebecca M.
    Cunanan, Kristen
    Neal, Joel W.
    Das, Millie
    Padda, Sukhmani K.
    Ramchandran, Kavitha
    Chen, Thomas T.
    Sequist, Lecia, V
    Piotrowska, Zofia
    Wakelee, Heather A.
    CLINICAL LUNG CANCER, 2022, 23 (03) : E210 - E221
  • [46] Active or Attractive? Oral Antiangiogenesis Therapy Plus EGFR Tyrosine Kinase Inhibitor in EGFR-Mutant NSCLC
    Liao, Bin-Chi
    Yang, James Chih-Hsin
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (09) : 1426 - 1428
  • [47] Osimertinib for patients with EGFR-mutant advanced NSCLC and asymptomatic brain metastases: An open-label, two-arm, phase II study
    Gillis, R.
    Peled, N.
    Goldshtien, I.
    Rotem, O.
    Rozenblum, A. B.
    Nechushtan, H.
    Chen, L.
    Dudnik, E.
    Zer, A.
    Yust-Katz, S.
    Shelef, I.
    Roisman, L. C.
    Inbar, E.
    ANNALS OF ONCOLOGY, 2019, 30
  • [48] Data from Real World to Evaluate the Efficacy of Almonertinib in EGFR-mutant NSCLC Patients
    Wang, H.
    Xing, R.
    Niu, Y.
    Zhang, M.
    Zhang, X.
    Li, M.
    Ma, Z.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S398 - S399
  • [49] Whole brain radiation therapy does not improve the overall survival of EGFR-mutant NSCLC patients with leptomeningeal metastasis
    Weiwei Yan
    Yang Liu
    Ji Li
    Anqin Han
    Li Kong
    Jinming Yu
    Hui Zhu
    Radiation Oncology, 14
  • [50] Whole brain radiation therapy does not improve the overall survival of EGFR-mutant NSCLC patients with leptomeningeal metastasis
    Yan, Weiwei
    Liu, Yang
    Li, Ji
    Han, Anqin
    Kong, Li
    Yu, Jinming
    Zhu, Hui
    RADIATION ONCOLOGY, 2019, 14 (01)
12345